1. WHO. WHO Director-General’s opening remarks at the media briefing on COVID-19 - 11 March 2020. https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020 (2020).
2. EMA. COVID-19 vaccines, Overview, European Medicines Agency. https://www.ema.europa.eu/en/human-regulatory/overview/public-health-threats/coronavirus-disease-covid-19/treatments-vaccines/covid-19-vaccines (2022).
3. EMA. COVID-19 Vaccine AstraZeneca: PRAC investigating cases of thromboembolic events-vaccine’s benefits currently still outweigh risks-Update. https://www.ema.europa.eu/en/news/covid-19-vaccine-astrazeneca-prac-investigating-cases-thromboembolic-events-vaccines-benefits (2021).
4. See, I. et al. US Case Reports of Cerebral Venous Sinus Thrombosis With Thrombocytopenia After Ad26.COV2.S Vaccination, March 2 to April 21, 2021. JAMA 325, 2448–2456 (2021).
5. Hocking, J. et al. The first known case of vaccine-induced thrombotic thrombocytopenia in Australia. Med. J. Aust. 215, 19–20 e11 (2021).